Expanding indications for recombinant human TSH in thyroid cancer
- PMID: 18630995
- PMCID: PMC2637556
- DOI: 10.1089/thy.2008.0162
Expanding indications for recombinant human TSH in thyroid cancer
Comment in
-
Recombinant human TSH: the Argentinean experience.Thyroid. 2009 Jul;19(7):799. doi: 10.1089/thy.2008.0259. Thyroid. 2009. PMID: 19508122 No abstract available.
Similar articles
-
Recombinant human thyrotropin in the management of thyroid cancer.Curr Opin Oncol. 2001 Jan;13(1):39-43. doi: 10.1097/00001622-200101000-00008. Curr Opin Oncol. 2001. PMID: 11148684 Review.
-
Recombinant human TSH: the Argentinean experience.Thyroid. 2009 Jul;19(7):799. doi: 10.1089/thy.2008.0259. Thyroid. 2009. PMID: 19508122 No abstract available.
-
Recombinant human TSH in differentiated thyroid cancer: a nuclear medicine perspective.Eur J Nucl Med Mol Imaging. 2008 Jul;35(7):1397-9. doi: 10.1007/s00259-008-0823-0. Epub 2008 May 10. Eur J Nucl Med Mol Imaging. 2008. PMID: 18470514 No abstract available.
-
How the availability of recombinant human TSH has changed the management of patients who have thyroid cancer.Nat Clin Pract Endocrinol Metab. 2007 Sep;3(9):641-50. doi: 10.1038/ncpendmet0594. Nat Clin Pract Endocrinol Metab. 2007. PMID: 17710085 Review.
-
The use of recombinant human TSH in a patient with metastatic follicular carcinoma and insufficient endogenous TSH production.J Endocrinol Invest. 2000 Jul-Aug;23(7):473-5. doi: 10.1007/BF03343758. J Endocrinol Invest. 2000. PMID: 11005273
Cited by
-
PET imaging of differentiated thyroid cancer with thyrotropin-alfa.Sci Rep. 2025 Apr 3;15(1):11375. doi: 10.1038/s41598-025-94923-0. Sci Rep. 2025. PMID: 40175460 Free PMC article.
-
Evaluation of whole-body retention of iodine-131 ((131)I) after postoperative remnant ablation for differentiated thyroid carcinoma - thyroxine withdrawal versus rhTSH administration: A retrospective comparison.Oncol Lett. 2012 Mar;3(3):617-620. doi: 10.3892/ol.2011.523. Epub 2011 Dec 14. Oncol Lett. 2012. PMID: 22740962 Free PMC article.
-
Adjuvant treatment with thyrotropin alpha for remnant ablation in thyroid cancer.Biologics. 2009;3:9-13. Epub 2009 Jul 13. Biologics. 2009. PMID: 19707391 Free PMC article.
-
Medium- and long-term recurrence after radioiodine therapy for differentiated thyroid carcinoma with recombinant human thyrotropin: a meta-analysis.Front Endocrinol (Lausanne). 2024 Dec 17;15:1474121. doi: 10.3389/fendo.2024.1474121. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39741877 Free PMC article.
-
Metastatic Differentiated Thyroid Cancer Survival Is Unaffected by Mode of Preparation for 131I Administration.J Endocr Soc. 2022 Mar 2;6(5):bvac032. doi: 10.1210/jendso/bvac032. eCollection 2022 May 1. J Endocr Soc. 2022. PMID: 35356009 Free PMC article.
References
-
- Duntas LH, Cooper DS. Review on the occasion of a decade of recombinant human TSH: prospects and novel uses. Thyroid. 2008;18:509–516. - PubMed
-
- Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Sherman SI, Tuttle RM. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2006;16:109–142. - PubMed
-
- Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol. 2006;154:787–803. - PubMed
-
- Zanotti-Fregonara P, Toubert ME, Taieb D, Ravasi L, Rubello D, Hindie E. Overview on the use of recombinant human thyrotropin in thyroid cancer of follicular origin. Minerva Endocrinol. 2008;33:53–65. - PubMed
-
- Hanscheid H, Lassmann M, Luster M, Thomas SR, Pacini F, Ceccarelli C, Ladenson PW, Wahl RL, Schlumberger M, Ricard M, Driedger A, Kloos RT, Sherman SI, Haugen BR, Carriere V, Corone C, Reiners C. Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or thyroid hormone withdrawal. J Nucl Med. 2006;47:648–654. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical